Pharmacokinetic Study of Milrinone in Babies With Persistent Pulmonary Hypertension of the Newborn
Status:
Terminated
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this pilot study is to determine a safe dose of milrinone to use in a larger
study of babies with persistent pulmonary hypertension of the newborn (PPHN).
Phase:
N/A
Details
Lead Sponsor:
Children's Hospital of Philadelphia
Collaborators:
American Medical Association Bedford Pharmaceuticals Thrasher Research Fund University of Pennsylvania